Boehringer Ingelheim and LEO Pharma have signed an exclusive global license and transfer agreement to commercialize and ...

PCI Pharma Services has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and ...

Kane will advance strategic priorities and advance Solrikitug, its lead asset, in Phase II trials and prepare for Phase III.

“With our new hot melt extrusion technology, Aenova is expanding its range of innovative platforms to provide modern, ...

Ofichem Group has agreed to acquire Avivia B.V., a company specialized in formulation development based in Nijmegen, the ...

The Flamma Group, a Contract Development and Manufacturing Organization (CDMO) of New Chemical Entities (NCEs) and late-stage ...

The antibody, ISB 2001, is currently in Phase 1 clinical trial in patients with relapsed/refractory multiple myeloma (R/R MM) ...

Aptar CSP Technologies, a leader in active material science, has developed a dual-active material science technology ...

Cellular Origins, the Cell and Gene Therapy Catapult, and Resolution Therapeutics have formed a consortium funded by Innovate ...

New appointments to the leadership team also include Stefan Larson as Chair of the Board of Directors and Ingmar Bruns as a ...

Merck, through a subsidiary, will acquire Verona Pharma for a total transaction value of approximately $10 billion.

Grand River Aseptic Manufacturing’s Tyler BeVier on strategic partnerships, cutting-edge capacity, and a patient-first ...